Smithfield Trust’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,750
Closed -$8K 1074
2022
Q3
$8K Hold
12,750
﹤0.01% 818
2022
Q2
$31K Hold
12,750
﹤0.01% 606
2022
Q1
$52K Buy
12,750
+7,650
+150% +$41.9K ﹤0.01% 549
2021
Q4
$41K Hold
5,100
﹤0.01% 590
2021
Q3
$98K Buy
+5,100
New +$89.1K 0.01% 443

Other funds holding PLXP

Smithfield Trust's PLXP Position: Q4 2022 in Review

Smithfield Trust sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 12,750 shares — an estimated $8K sold.

Smithfield Trust first reported a position in PLXP in Q3 2021 and held it in 5 quarters. The position peaked at $98K in Q3 2021. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • Smithfield Trust reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Smithfield Trust sold 12,750 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $8K.
  • Smithfield Trust first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Smithfield Trust's PLx Pharma Inc. Common Stock position peaked at $98K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on Smithfield Trust's 13F filing for Q4 2022, filed 13 Feb 2023.